This may be related to the impact of immunosuppression on the underlying liver disease such as nonalcoholic steatohepatitis and chronic hepatitis C virus infection.23Whether the clinical relevance of PTMS in liver transplant patients is the same as that of the general population with metabolic syndrome is an important question.